Michael P Blair1, Debra A Goldstein, Michael J Shapiro. Show Affiliations » 1. Department of Ophthalmology and Visual Science, University of Illinois at Chicago, USA. mblair2@uic.edu
Abstract
Entities: Disease
Mesh： See more » Acyclovir/analogs & derivativesAcyclovir/therapeutic useAdultAntiretroviral Therapy, Highly ActiveAntiviral Agents/therapeutic useCD4 Lymphocyte CountDrug Therapy, CombinationFemaleFoscarnet/therapeutic useGanciclovir/therapeutic useHIV Infections/diagnosisHIV Infections/drug therapyHIV Infections/virologyHIV-1/isolation & purificationHIV-2/isolation & purificationHerpes Zoster Ophthalmicus/diagnosisHerpes Zoster Ophthalmicus/drug therapyHerpes Zoster Ophthalmicus/virologyHerpesvirus 3, Human/isolation & purificationHumansInfusions, IntravenousRetinal Necrosis Syndrome, Acute/diagnosisRetinal Necrosis Syndrome, Acute/drug therapyRetinal Necrosis Syndrome, Acute/virologyTomography, Optical CoherenceValacyclovirValine/analogs & derivativesValine/therapeutic useVitreous Body/virology
Substances： See more » Antiviral AgentsFoscarnetValineValacyclovirGanciclovirAcyclovir
Year: 2007 PMID： 18046245 DOI： 10.1097/IAE.0b013e3180cc2630
Source DB: PubMed Journal: Retina ISSN： 0275-004X Impact factor: 4.256